HNMPA
CAS No. 132541-52-7
HNMPA ( —— )
产品货号. M27459 CAS No. 132541-52-7
HNMPA 是胰岛素受体酪氨酸激酶抑制剂,抑制人胰岛素受体的丝氨酸和酪氨酸自磷酸化。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥681 | 有现货 |
|
| 5MG | ¥947 | 有现货 |
|
| 10MG | ¥1758 | 有现货 |
|
| 25MG | ¥2911 | 有现货 |
|
| 50MG | ¥4259 | 有现货 |
|
| 100MG | ¥5904 | 有现货 |
|
| 500MG | ¥11880 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥1093 | 有现货 |
|
生物学信息
-
产品名称HNMPA
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述HNMPA 是胰岛素受体酪氨酸激酶抑制剂,抑制人胰岛素受体的丝氨酸和酪氨酸自磷酸化。
-
产品描述HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.(In Vitro):HNMPA reduces neuronal firing after GABA application and blocks GABA-dependent insulin inhibition. HNMPA has no effect on cyclic AMP-dependent protein kinase or protein kinase C activities.
-
体外实验HNMPA inhibits the phosphorylation of a synthetic peptide substrate composed of insulin receptor residues 1290-1319 on serines-1305/1306 by partially purified insulin receptors.HNMPA blocks GABA-dependent insulin inhibition, and reduces neuronal firing after GABA application.
-
体内实验——
-
同义词——
-
通路Angiogenesis
-
靶点IGF-1R
-
受体DNMT3B|Parasite|antimalarial
-
研究领域——
-
适应症——
化学信息
-
CAS Number132541-52-7
-
分子量238.18
-
分子式C11H11O4P
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=P(O)(O)C(O)C=1C=CC=2C=CC=CC2C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
AZ7550 trimesylate s...
AZ7550 Mesylate 是 AZD9291 的一种活性代谢物,AZ7550 抑制 IGF1R 活性,IC50 为 1.6 μM。
-
KW-2450 free base
KW-2450 free base is an orally bioavailable inhibitor of insulin-like growth factor 1 receptor (IGF-1R) and insulin receptor (IR) tyrosine kinases with potential antineoplastic activity. IGF-1R/IR inhibitor KW-2450 free base selectively binds to and inhibits the activities of IGF-1R and IR, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. IGF-R1 and IR tyrosine kinases, overexpressed in a variety of human cancers, play significant roles in the stimulation of cellular proliferation, oncogenic transformation, and suppression of apoptosis.
-
Ganitumab
Ganitumab (AMG 479) 是一种重组人1型胰岛素样生长因子受体 (IGF1R) 单克隆抗体。Ganitumab 识别具有亚纳米摩尔亲和力的小鼠 IGF1R (KD=0.22 nM),并抑制小鼠 IGF1R 与 IGF1 和 IGF2 的相互作用。Ganitumab 可用于癌症研究。
021-51111890
购物车()
sales@molnova.cn

